Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
RAS wild-type + BRAF wild-type
i
Other names:
BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
673
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
(7)
News
Trials
Search handles
Search handles
Filter by
Latest
almost2years
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study. Talk by Dr. Benoist Chibaudel, MD #ASCO22 #CRCSM (@manjuggm)
almost 2 years ago
Clinical • P3 data
|
KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene)
|
KRAS wild-type • RAS wild-type • NRAS wild-type • RAS wild-type + BRAF wild-type
almost2years
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study. Talk by Dr. Benoist Chibaudel, MD #ASCO22 #CRCSM @OncoAlert (@manjuggm)
almost 2 years ago
Clinical • P3 data
|
KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene)
|
KRAS wild-type • RAS wild-type • NRAS wild-type • RAS wild-type + BRAF wild-type
almost2years
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study. Talk by Dr. Benoist Chibaudel, MD #ASCO22 #CRCSM (@manjuggm)
almost 2 years ago
Clinical • P3 data
|
KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene)
|
KRAS wild-type • RAS wild-type • NRAS wild-type • RAS wild-type + BRAF wild-type
almost2years
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study. Talk by Dr. Benoist Chibaudel, MD #ASCO22 #CRCSM (@manjuggm)
almost 2 years ago
Clinical • P3 data
|
KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene)
|
KRAS wild-type • RAS wild-type • NRAS wild-type • RAS wild-type + BRAF wild-type
almost2years
STRATEGIC-1: Multi-line therapy trial in unresectable wild-type KRAS/NRAS/BRAF metastatic colorectal cancer—A GERCOR-PRODIGE randomized open-label phase III study. Talk by Dr. Benoist Chibaudel, MD #ASCO22 #CRCSM (@manjuggm)
almost 2 years ago
Clinical • P3 data
|
KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene)
|
KRAS wild-type • RAS wild-type • NRAS wild-type • RAS wild-type + BRAF wild-type
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login